Artificial Sweetener Sucralose May Reduce Effectiveness of Cancer Immunotherapy
Emerging research indicates that the artificial sweetener sucralose may reduce the effectiveness of cancer immunotherapy by altering gut microbiota and immune cell function. Learn what this means for cancer patients and their dietary choices.
Artificial Sweetener Sucralose and Cancer Immunotherapy
Artificial sweeteners, commonly used to reduce calorie intake in diet foods and beverages, have raised health concerns, including links to gastrointestinal issues, metabolic problems, and potential cancer risks. Recent research suggests that sucralose, one of the most popular sweeteners, may impair cancer immunotherapy effectiveness.
Studies demonstrate that sucralose alters gut microbiota, decreasing bacteria that produce the amino acid arginine, crucial for immune cells to attack cancer. Experiments in mice showed increased tumor growth and diminished T-cell activity when fed high sucralose levels. Additionally, human studies linked high sucralose intake with poorer responses to immunotherapy in lung and melanoma cancers.
Experts warn that consuming large quantities of sucralose, such as through diet sodas, could compromise cancer treatments. Supplementing with arginine or citrulline might counteract these effects, offering a potential strategy for patients. Researchers advocate for further investigations but currently recommend minimizing artificial sweetener intake during immunotherapy treatments.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Urinary Microbes and Their Role in Supporting Prostate Cancer Growth Through Hormone Alteration
Emerging research highlights how bacteria in the urinary tract can promote prostate cancer growth by converting steroids into androgens, revealing new avenues for hormonal cancer treatments.
Innovative Blood-Based Biosensor Promises Improved PTSD Diagnosis
Researchers have developed a novel blood-based biosensor using multiomic technology to enhance the accuracy and speed of PTSD diagnosis, paving the way for personalized mental health treatment.
Genetic Mutation Influences Iron Deficiency in Crohn's Disease Patients
A groundbreaking study reveals how genetic mutations in PTPN2 impair iron absorption, leading to anemia in Crohn's disease patients, paving the way for personalized therapies.
Histotripsy Enhances Immune Response to Combat Cancer Outside the Liver
Histotripsy, a cutting-edge ultrasound-based therapy, not only destroys liver tumors but also stimulates the immune system to fight cancer cells beyond the liver, opening new avenues for non-invasive cancer treatments.